Metformin and sitAgliptin in patients with impAired glucose tolerance and a recent TIA or minor ischemic Stroke (MAAS): study protocol for a randomized controlled trial

BACKGROUND: Impaired glucose tolerance is present in one third of patients with a TIA or ischemic stroke and is associated with a two-fold risk of recurrent stroke. Metformin improves glucose tolerance, but often leads to side effects. The aim of this study is to explore the feasibility, safety, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Osei, Elizabeth, Fonville, Susanne, Zandbergen, Adrienne A. M., Brouwers, Paul J. A. M., Mulder, Laus J. M. M., Lingsma, Hester F., Dippel, Diederik W. J., Koudstaal, Peter J., den Hertog, Heleen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526305/
https://www.ncbi.nlm.nih.gov/pubmed/26242578
http://dx.doi.org/10.1186/s13063-015-0882-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526305/
https://www.ncbi.nlm.nih.gov/pubmed/26242578
http://dx.doi.org/10.1186/s13063-015-0882-z

Ejemplares similares